NICKEISHA PILGRIM: Open Payments
NPI 1740953876 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,944 in 27 payments from 18 companies in 2025. Trend: 2023 $1,849 · 2024 $3,028 · 2025 $2,944
Food & beverage: $2,944
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $658 |
| Teva Pharmaceuticals USA, Inc. | 2 | $242 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $219 |
| Sage Therapeutics, LLC | 2 | $196 |
| Organogenesis Inc. | 1 | $174 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $168 |
| Janssen Biotech, Inc. | 1 | $140 |
| Dexcom, Inc. | 1 | $135 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| Avanos Medical | 2 | $119 |
Products named: TAVNEOS, NEFFY, APLIGRAF, REPATHA, TREMFYA, DEXCOM G7 GSS (161), KRYSTEXXA, FASENRA.
Industry payments across MD — which companies pay providers there.
